SELLAS Life Sciences Group, Inc.
SLS
$1.92
$0.0955.22%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -26.26M | -27.13M | -30.88M | -32.28M | -34.44M |
Total Depreciation and Amortization | -- | -- | -- | -- | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 2.34M | 2.16M | 2.13M | 2.23M | 2.38M |
Change in Net Operating Assets | -7.44M | -8.75M | -6.65M | -3.02M | -97.00K |
Cash from Operations | -31.36M | -33.71M | -35.40M | -33.07M | -32.16M |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | 0.00 | -3.00M |
Cash from Investing | -- | -- | -- | 0.00 | -3.00M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 47.57M | 43.76M | 46.82M | 50.17M | 30.53M |
Repurchase of Common Stock | -64.00K | -64.00K | -64.00K | -31.00K | -31.00K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 47.51M | 43.69M | 46.76M | 50.14M | 30.50M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 16.15M | 9.98M | 11.36M | 17.06M | -4.66M |